Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 8EOI | Q9P0I2 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q5J8M3 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q8N4V1 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q9BV81 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q9NPA0 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | O43402 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q5UCC4 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | P54286 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8EOI | Q13936 | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | |
| 8F60 | 8F60 | anti-BTLA monoclonal antibody r23C8 in complex with BTLA | |
| 8F60 | Q7Z6A9 | anti-BTLA monoclonal antibody r23C8 in complex with BTLA | |
| 8G6I | P00451 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G6I | P12263 | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G6I | 8G6I | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8GB5 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
| 8GB5 | 8GB5 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
| 8GB6 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
| 8GB6 | 8GB6 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
| 8GB7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB7 | 8GB7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB8 | P0DTC2 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB8 | 8GB8 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GFM | A0A3I4HTM2 | Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with zanamivir amine inhibitor | |
| 8GFP | A0A3I4HTM2 | Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with N-acetyl-2,3-dehydro-2-deoxyneuraminic acid inhibitor | |
| 8GFQ | A0A3I4HTM2 | Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv32r inhibitor | |
| 8IOS | P0DTC2 | Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state) | |
| 8IOT | P0DTC2 | Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state) | |
| 8IOU | P0DTC2 | Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) | |
| 8IOU | Q9BYF1 | Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) | |
| 8IOV | Q9BYF1 | Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 | |
| 8IOV | P0DTC2 | Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 | |
| 8A1U | Q9KPS1 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8A1U | Q9KPS2 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8A1U | P0C6E0 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8A1U | Q9X4Q6 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8A1U | Q9X4Q7 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8A1U | Q9X4Q8 | Sodium pumping NADH-quinone oxidoreductase with substrates NADH and Q2 | |
| 8EDF | P0DTC2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOX5 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | 8EDF | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOX5 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | 8EDF | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOY2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EDF | P0DOY2 | Bovine Fab SKD in complex with Sars COV-2 receptor binding domain | |
| 8EFJ | P47811 | A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds | |
| 8FOI | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | P63137 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | P22723 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8FOI | 8FOI | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8G4N | P62812 | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroids |
